Clinical trials show that tirzepatide can help patients lose up to 20-22% of their body weight (New England Journal of Medicine, 2022)
Wegovy (semaglutide 2.4 mg) carries a separate FDA approval for chronic weight management and sits on a different formulary pathway entirely
Silymarin has been reported to act as an antioxidant by reducing free radical production and lipid peroxidation, function as a toxin blocker by inhibiting the binding of toxins to the hepatocyte cell membrane receptors (Abenavoli et al., 2010), and reduce the superoxide and peroxynitrite content by its scavenger activity (Papackova et al., 2018)
CJC-1295 is a growth hormonereleasing hormone (GHRH) analog that stimulates the anterior pituitary to secrete more GH
A 2025 University of Washington study investigated intranasal administration of GHK-Cu in a transgenic mouse model of Alzheimer's disease, finding reduced neuroinflammation and improved astrocyte function [7]
The key is to identify the subgroup that needs closer retinal follow-up